NAC eye drops provide those suffering from cataracts a breakthrough alternative to cataract surgery. This cataract melting formula discovered by Dr. Babizhayev and his research team delivers powerful anti-oxidant benefits and has generated amazing curative results for people around the world.
NAC is the name we commonly use to refer to N-Acetylcarnosine. N-Acetylcarnosine is a naturally occurring compound chemically related to the dipeptide carnosine. Other than the fact that it carries an additional acetyl group, NAC molecular structure is identical to carnosine. Carnosine is found in the heart and skeletal muscles and is believed to have anti-oxidant properties.
Oxidative stress is one of the implications for the chemical reactions that lead to destructive age related cross linking and aggregation of proteins. Unlike most dipeptides, carnosine is not derived from proteins, and is soluble in water but not in lipids (fats). As a result of this characteristic, carnosine has difficulty penetrating through cell membranes made of lipids, however N-acetylcarnosine is relatively soluble in lipids and in water and can therefore pass through cell membranes. Once inside the cellular level, NAC is broken down into carnosine and the benefits can be derived.
Since NAC eye drops have N-acetylcarnosine, they are highly resistant to break down and have slow release characteristics making them highly effective in treating cataracts. These drops will deliver a powerful anti-oxidant boost to your eyes, protecting you from the potential for cataracts and improving existing cataract condition.
Background and Research:
The breakthrough behind NAC took place in the 1990’s as a result of research done by Dr. Mark Babizhayev and his Russian research team. During early experiments performed at the Moscow Helmholtz Research Institute for Eye Diseases, it was shown that NAC (1% concentration), was able to pass from the cornea to the aqueous humour after about 15 to 30 minutes.